IEEE Spectrum on MSN
Why the most accurate glucose monitors are failing some users
For diabetics who rely on them, lived experience trumps metrics ...
Stelo by Dexcom is a wearable glucose biosensor that brings continuous glucose monitoring into the consumer wellness space, ...
Young and the Invested on MSN
7 best growth stocks to buy for 2026
Growth stocks are still on the menu for 2026. The first few months of 2025 were a roller-coaster ride that threatened to ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. The company said its Smart Basal ...
Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback